Efficacy and Safety of Masitinib in Combination With SoC Versus Placebo in the Treatment of ALS Patients
Clinical trial NCT07174492 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07174492
- Sponsor
- AB Science
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-01
- Primary completion
- 2028-12-31
- Enrollment
- 412
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.